Glenmark launches oral drug for Psoriasis treatment in India

The Mumbai-based company has launched Apremilast under the brand name Aprezo. It has received approval from DCGI for Apremilast after conducting clinical trials on the molecule as per the regulatory requirements.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news